Table 1 Summary of included studies in this meta-analysis
Studies | Study design | Total case (n) | Population | MetS rate | MetS definition | Follow-up, (years) | AF rate |
|---|---|---|---|---|---|---|---|
Choe-2019 | Retrospective cohort study | 22,886,663 | Korean (aged > 40 years) from the Korean National Health Insurance Service from 2008 to 2013 | 27.4% | NCEP-ATPIII | 5.4 | 0.98% |
Kwon-2019 | Retrospective cohort study | 7,830,602 | Korean (aged 30–69 years) from the Korean National Health Insurance Service from 2009 to 2016 | 15.9% | NCEP-ATPIII | 7.3 | 0.26% |
Kim-2018 | Prospective cohort study | 21,981 | Korean men from a health screening program from 2003 to 2008 | 11.5% | International Diabetes Federation | 8.7 | 0.8% |
Chamberlain-2010 | Prospective cohort study | 15,094 | American (aged 45–64 years) from Atherosclerosis Risk in Communities study from 1987–1989 | 41.1% | AHA/NHLBI | 15.4 | 8.2% |
Nyström-2015 | Prospective cohort study | 4,021 | Stockholmer (aged 60 years) from a health-screening study in Stockholm from August 1997 to March 1999 | 27.6% | Other definition standards | 13.6 | 7.1% |
Watanabe-2008 | Prospective cohort study | 28,449 | Japanese (aged ≥ 20 years) from an annual health examination at the Niigata Association for Comprehensive Health Promotion and Research | 13% for NCEP-ATPIII; 16% for AHA/NHLBI | NCEP-ATPIII or AHA/NHLBI | 4.5 | 0.9% |